BioSante Pharmaceuticals, Inc. Presents LibiGel(R) Clinical and Market Information at ISSWSH Conference

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), presented LibiGel clinical and market information at the 2009 Annual Meeting of the International Society for the Study of Women’s Sexual Health (ISSWSH).

MORE ON THIS TOPIC